Hong Kong Exchange: Nurturing China’s Biotech Valley
Health Advances
SEPTEMBER 15, 2020
Despite the well-publicized ongoing political issues in Hong Kong SAR, Health Advances believes that HKEX’s unique position and the sustained growth of China’s healthcare industry will continue to attract Chinese biotech companies with domestic and global-focused strategies to the exchange. HKEX: Opening a Biotech Chapter. explains Chen.
98 
Let's personalize your content